Amgen Inc. AMGN
414.61
8.57
2.11%
as of 25 Sep
- Market cap
- $219.1B
- P/E
- 25.6×
Follow AMGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Amgen Inc. (AMGN) Book value per share
Amgen Inc.'s book value per share at the end of fiscal 2025 was 16.1×, up 47.0% from 10.9× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 21.6×. Over the past ten years it has ranged from 6.8× (fiscal 2022) to 39.9× (fiscal 2016); the current reading is higher than 64% of that period. Amgen Inc. ranks 7th of 21 Drug Manufacturers General companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 16.1× | 47.05% |
| FY2024 | 10.9× | (6.05%) |
| FY2023 | 11.6× | 71.18% |
| FY2022 | 6.8× | (42.11%) |
| FY2021 | 11.8× | (26.79%) |
| FY2020 | 16.1× | 0.42% |
| FY2019 | 16.0× | (15.45%) |
| FY2018 | 18.9× | (45.23%) |
| FY2017 | 34.5× | (13.55%) |
| FY2016 | 39.9× | 7.80% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 21.6× | 27.18% |
| Mar 2026 | 17.0× | 5.75% |
| Dec 2025 | 16.1× | (9.99%) |
| Sep 2025 | 17.9× | 29.50% |
| 42 more quarters | Free account |
Against its own ten years
Low 6.8×
High 39.9×
Ten-year median
16.1×
Current reading's percentile
64
Book value per share against peers
| Company | Book value per share |
|---|---|
| AZN AstraZeneca PLC compare | 32.5× |
| NVS Novartis AG compare | 22.0× |
| AMGN Amgen Inc. | 21.6× |
| MRK Merck & Co., Inc. compare | 17.0× |
| PFE Pfizer Inc. compare | 15.0× |
| BMY Bristol Myers Squibb Company compare | 10.9× |
| GILD Gilead Sciences, Inc. compare | 9.4× |
| NVO Novo Nordisk A/S compare | 7.8× |
| ABBV AbbVie Inc. compare | −3.3× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on AMGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement